Company Filing History:
Years Active: 2002-2004
Title: Francesca Abrate: Innovator in Matrix Metalloproteinase Inhibitors
Introduction
Francesca Abrate is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of matrix metalloproteinase inhibitors. With a total of 2 patents, her work has the potential to impact the treatment of various diseases.
Latest Patents
Francesca's latest patents include innovative compounds such as 3-arylsulfonyl-2 (substituted methyl) propanoic acid derivatives. These compounds exhibit potent and selective inhibitory activity against matrix metalloproteinases (MMPs), which are crucial in the treatment and prevention of diseases mediated by MMPs. Another notable patent involves amine derivatives that inhibit the release of tumor necrosis factor-alpha (TNF) from cells, making them valuable in addressing tumoral and inflammatory diseases.
Career Highlights
Throughout her career, Francesca has worked with notable companies such as Pharmacia Italia S.p.a. and Pharmacia & Upjohn S.p.a. Her expertise in pharmaceutical research has led to advancements in drug development and therapeutic applications.
Collaborations
Francesca has collaborated with esteemed colleagues, including Pierluigi Bissolino and Ettore Perrone. These partnerships have fostered innovation and contributed to her success in the field.
Conclusion
Francesca Abrate's work in matrix metalloproteinase inhibitors showcases her dedication to advancing medical science. Her patents and collaborations reflect her significant impact on pharmaceutical research and development.